Novartis | NOVN - Current Assets

Stock Price
129.22
Daily Change
1.24 0.97%
Monthly
11.51%
Yearly
28.30%
Q1 Forecast
123.39

Novartis reported $28.2B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alcon AG USD 6.33B 27M Sep/2025
Almirall EUR 713.98M 69K Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Autolus Therapeutics Ltd USD 514.58M 59.67M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.82B 311.36M Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
J&J USD 55.62B 1.01B Dec/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Orion EUR 1.34B 247.2M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Philips EUR 9.93B 654M Dec/2025
Recordati EUR 1.71B 144.32M Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024